Delivery Order SPE2DB24D8002-SPE2DB24FJMXT

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,094.61 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Jardiance 25 mg tablets. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4,566,188 units of the pharmaceutical product JARDIANCE 10 MG TABLET 90S. The contract, valued at $10,284.01, has an ultimate completion date of October 24, 2024. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 90 tablets of the pharmaceutical product Jardiance 10 mg. The contract has a ceiling value of $5,347.67 and a period of performance through November 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows Dakota...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,703.89 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a period of performance through November 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC...
This award is a Delivery Order contract valued at $3,052.83, issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication. This order is part of Dakota Drug's single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,076.98, is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication. The contract is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA Troop Support Medical's ECAT Generation V Program, which has...
This is a $9,135.66 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication, to support the DLA Troop Support Medical's medical supply chain operations. This delivery order is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which allows the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,411.33 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of JARDIANCE 25 MG TABLET 30S. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a major indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,204.90 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Jardiance 10 mg tablets. This contract, which has a performance period ending on May 10, 2023, is part of the DLA Troop Support Medical's ECAT Generation V Program, a significant Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that allows Dakota Drug, Inc. to supply a wide...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,231,498 units of Jardiance 10 MG Tablet 90s medication. The contract has a ceiling value of $3,643.63 and a period of performance through July 24, 2024. This order is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJMXT
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,065.59 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 4565768026 - JARDIANCE 10 MG TABLET 90S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Dakota Drug, Inc. holds with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. The contract has an ultimate completion date of September 12, 2024 and does not have a set-aside designation.

Generated 12/11/24, 9:17 AM